Literature DB >> 2995864

Autoradiographic localization of mu, delta and kappa opioid receptor binding sites in rat and guinea pig spinal cord.

C Gouardères, J Cros, R Quirion.   

Abstract

The autoradiographic distribution of mu, delta and kappa opioid binding sites was evaluated in various segments of the rat and guinea pig spinal cord. Mu opioid receptor binding sites are highly concentrated in the superficial layers of the dorsal horn (laminae II and III) in both species, without any marked gradient along the cord. Delta binding sites are somewhat concentrated in the superficial layers of the dorsal horn. However, delta binding sites are also present and evenly distributed in other areas of the gray matter. The highest density of delta sites is found in the cervical segment with only low levels in the lumbo-sacral region of the rat and guinea pig spinal cord. Kappa opioid binding sites are highly concentrated in the superficial layers of the dorsal horn of the spinal cord. Lower levels are seen in the rest of the gray matter with some enrichment in lamina X. Moreover, the lumbo-sacral portion of the spinal cord is enriched in kappa sites as compared to the cervical and thoracic segments. These data demonstrate the differential laminar distribution of mu, delta and kappa opioid binding sites in rat and guinea pig spinal cord.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2995864     DOI: 10.1016/0143-4179(85)90006-x

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  10 in total

Review 1.  Regulatory peptide receptors: visualization by autoradiography.

Authors:  J M Palacios; M M Dietl
Journal:  Experientia       Date:  1987-07-15

2.  Mechanisms of inhibitory action of TRK-130 (Naltalimide), a μ-opioid receptor partial agonist, on the micturition reflex.

Authors:  Morihiro Fujimura; Naoki Izumimoto; Sayoko Kanie; Ryosuke Kobayashi; Satoru Yoshikawa; Shinobu Momen; Mikito Hirakata; Toshikazu Komagata; Satoshi Okanishi; Masashi Iwata; Tadatoshi Hashimoto; Takayuki Doi; Naoki Yoshimura; Koji Kawai
Journal:  Int Urol Nephrol       Date:  2017-01-16       Impact factor: 2.370

3.  Distinct distribution of opioid receptor types in rat lumbar spinal cord.

Authors:  B J Morris; A Herz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

4.  Influence of intramuscular heat stimulation on modulation of nociception: complex role of central opioid receptors in descending facilitation and inhibition.

Authors:  Hao-Jun You; Jing Lei; Gang Ye; Xiao-Li Fan; Qiang Li
Journal:  J Physiol       Date:  2014-07-18       Impact factor: 5.182

5.  Pharmacological mechanisms of alcohol analgesic-like properties in mouse models of acute and chronic pain.

Authors:  Bradley Neddenriep; Deniz Bagdas; Katherine M Contreras; Joseph W Ditre; Jennifer T Wolstenholme; Michael F Miles; M Imad Damaj
Journal:  Neuropharmacology       Date:  2019-09-25       Impact factor: 5.250

6.  Opioid-mediated regulation of A11 diencephalospinal dopamine neurons: pharmacological evidence of activation by morphine.

Authors:  Samuel S Pappas; Tom Kennedy; John L Goudreau; Keith J Lookingland
Journal:  Neuropharmacology       Date:  2011-05-13       Impact factor: 5.250

7.  Opioid receptor binding in rat spinal cord.

Authors:  S A Krumins
Journal:  Neurochem Res       Date:  1987-03       Impact factor: 3.996

8.  Delta-opioid mediated inhibitions of acute and prolonged noxious-evoked responses in rat dorsal horn neurones.

Authors:  A F Sullivan; A H Dickenson; B P Roques
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

9.  Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.

Authors:  C Gouardères; K Jhamandas; M Sutak; J M Zajac
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

Review 10.  Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics.

Authors:  Tuan Trang; Ream Al-Hasani; Daniela Salvemini; Michael W Salter; Howard Gutstein; Catherine M Cahill
Journal:  J Neurosci       Date:  2015-10-14       Impact factor: 6.167

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.